Baolingbao Biology Co.,Ltd. (SHE:002286)
China · Delayed Price · Currency is CNY 10.72
-0.30 (-2.72%)
Sep 3, 2025, 2:45 PM CST
Baolingbao Biology Market Cap
Baolingbao Biology has a market cap or net worth of 4.19 billion as of September 3, 2025. Its market cap has increased by 80.10% in one year.
Market Cap
4.19B
Enterprise Value
4.23B
Revenue
2.62B
Ranking
n/a
PE Ratio
30.60
Stock Price
10.72
Market Cap Chart
Since August 28, 2009, Baolingbao Biology's market cap has increased from 1.81B to 4.19B, an increase of 131.87%. That is a compound annual growth rate of 5.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2025 | 4.26B | 56.01% |
| Dec 31, 2024 | 2.73B | -9.36% |
| Dec 29, 2023 | 3.01B | -10.92% |
| Dec 30, 2022 | 3.38B | -32.78% |
| Dec 31, 2021 | 5.03B | 19.45% |
| Dec 31, 2020 | 4.21B | 89.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 458.07B |
| WuXi AppTec | 325.94B |
| Shenzhen Mindray Bio-Medical Electronics | 298.09B |
| Sichuan Biokin Pharmaceutical | 144.99B |
| Zhangzhou Pientzehuang Pharmaceutical., | 124.36B |
| Shanghai United Imaging Healthcare | 123.46B |
| Aier Eye Hospital Group | 120.84B |
| Yunnan Baiyao Group Co.,Ltd | 106.50B |